VOR

Vor Biopharma Inc. is an innovative biopharmaceutical company based in Cambridge, Massachusetts, specializing in the development of engineered hematopoietic stem cell (eHSC) therapies designed to enhance cancer treatment outcomes. Leveraging proprietary technology platforms, Vor aims to deliver targeted therapies that promise durable responses and improved overall survival rates for patients. With its commitment to advancing cell therapies, Vor is well-positioned within the rapidly evolving oncology market, offering compelling investment opportunities for institutional investors keen on supporting groundbreaking solutions in cancer therapeutics.